Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR/rictor-independent Akt activation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples